How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

1,981 results for

Cholesterol Education Resources

Latest & greatest

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

201. Well-Woman Visit

Well-Woman Visit Well-Woman Visit - ACOG Menu ▼ Well-Woman Visit Page Navigation ▼ Number 755 (Replaces Committee Opinion Number 534, August 2012) Committee on Gynecologic Practice This Committee Opinion was developed by the American College of Obstetricians and Gynecologists’ Committee on Gynecologic Practice in collaboration with committee member Catherine Witkop, MD, MPH. This information is designed as an educational resource to aid clinicians in providing obstetric and gynecologic care (...) , and use of this information is voluntary. This information should not be considered as inclusive of all proper treatments or methods of care or as a statement of the standard of care. It is not intended to substitute for the independent professional judgment of the treating clinician. Variations in practice may be warranted when, in the reasonable judgment of the treating clinician, such course of action is indicated by the condition of the patient, limitations of available resources, or advances

2018 American College of Obstetricians and Gynecologists

202. What national and subnational interventions and policies based on Mediterranean and Nordic diets are recommended or implemented in the WHO European Region, and is there evidence of effectiveness in reducing noncommunicable diseases?

national NCD outcomes? 27 ? 3. Discussion 29 ? 3.1. Strengths and limitations of this review 29 ? 3.2. Diet policy and evidence translation 29 ? 3.3. Monitoring and evaluation 31 ? 3.4. Frameworks to support MD- and ND-based policies, programmes and interventions 32 ? 3.5. Policy implications and options 33 ? 4. Conclusions 37 ? References 38 ? Annex 1. Search strategy 48 ? Annex 2. Resources to guide the implementation of report recommendations 55 ? Annex 3. Glossary 58iv iv ABBREVIATIONS CVD (...) reviewers Cécile Duvelle Former Secretary of the Convention for the Safeguarding of the Intangible Cultural Heritage (2008–2015), United Nations Educational, Scientific and Cultural Organization, Paris, France Pedro Graça Professor, Directorate General of Health/Faculty of Nutrition, University of Porto, Porto, Portugal Satu Männistö Research Manager, National Institute for Health and Welfare, Department of Public Health Solutions, Helsinki, Finland Ursula Schwab Professor of Nutrition Therapy

2018 WHO Health Evidence Network

203. Erectile Dysfunction

. Nelson, PhD; Hossein Sadeghi-Nejad, MD; Allen D. Seftel, MD; Alan W. Shindel, MD Copyright © 2018 American Urological Association Education and Research, Inc.® The Panel would like to dedicate this Guideline to the memory of our friend and colleague, Ralph Alterowitz. We will forever be grateful to his contributions and devotion to the field of men’s sexual health. He brought compassion and joy to all of those who were fortunate enough to work with him. 2 American Urological Association (AUA (...) ) Copyright © 2018 American Urological Association Education and Research, Inc.® Guideline Statements: Evaluation and Diagnosis: 1. Men presenting with symptoms of ED should undergo a thorough medical, sexual, and psychosocial history; a physical examination; and selective laboratory testing. (Clinical Principle) 2. For the man with ED, validated questionnaires are recommended to assess the severity of ED, to measure treat- ment effectiveness, and to guide future management. (Expert Opinion) 3. Men should

2018 American Urological Association

204. Atherosclerotic Cardiovascular Disease in South Asians in the United States: Epidemiology, Risk Factors, and Treatments: A Scientific Statement From the American Heart Association

of the world’s population and are one of the fastest-growing ethnic groups in the United States. Although native South Asians share genetic and cultural risk factors with South Asians abroad, South Asians in the United States can differ in socioeconomic status, education, healthcare behaviors, attitudes, and health insurance, which can affect their risk and the treatment and outcomes of atherosclerotic cardiovascular disease (ASCVD). South Asians have higher proportional mortality rates from ASCVD compared (...) disease (ASCVD) risk in South Asians compared with other populations. Cardiovascular disease (CVD) and diabetes mellitus (DM) have also been shown to be more frequent among Fiji Indians. , Although people living in South Asian countries share genetic and cultural risk factors with South Asians living abroad, South Asians residing in the United States can differ in socioeconomic status, education, healthcare behaviors, attitudes, and health insurance, which can affect their risk and the treatment

Full Text available with Trip Pro

2018 American Heart Association

205. Interdisciplinary Models for Research and Clinical Endeavors in Genomic Medicine: A Scientific Statement From the American Heart Association

lipid traits; in 1 notable example, they found that loss-of-function variants in APOB were associated with decreased low-density lipoprotein cholesterol levels and triglyceride levels but also increased alanine and aspartate aminotransferase levels, consistent with hepatocyte injury. Notably, patients receiving the APOB -targeting medication mipomersen experience lower low-density lipoprotein cholesterol levels and, in some cases, elevated hepatic transaminases or other liver conditions (...) identified a number of associations, with the most intriguing finding being that methylation of a CpG site near the ABCG1 gene was correlated with decreased expression of the gene, a known regulator of macrophage cholesterol efflux and reverse cholesterol transport; increased triglycerides and decreased high-density lipoprotein cholesterol; and substantially increased risk of coronary artery disease. Transcriptomic analyses of peripheral blood mononuclear cells from patients with and without coronary

Full Text available with Trip Pro

2018 American Heart Association

206. Promoting Risk Identification and Reduction of Cardiovascular Disease in Women Through Collaboration With Obstetricians and Gynecologists: A Presidential Advisory From the American Heart Association and the American College of Obstetricians and Gynecologi

, including standardized protocols and enhanced cardiac screening. Shared information can be used to assess risk, initiate interventions, and facilitate significant lifestyle changes. Care can be coordinated to minimize cardiovascular morbidity and mortality and to improve outcomes. By providing a platform for comprehensive well-woman care, primary prevention, and early intervention, providers of women’s health can provide patient education, empowerment, and motivation. Educational Resources Primary care (...) for cardiovascular risk factors. Hypercholesterolemia imparts the highest population-adjusted cardiovascular risk for women at 47%; benefits of statin therapy are similar for women and men. , The new Pooled Cohort Risk Equations, which are gender-specific and should be used for cholesterol management with lifestyle guidelines, are applicable to both genders. Given that 2 of 3 women in the United States are either obese or overweight, we must be cognizant of the adverse associations that increased weight has

Full Text available with Trip Pro

2018 American Heart Association

207. Health Literacy and Cardiovascular Disease: Fundamental Relevance to Primary and Secondary Prevention: A Scientific Statement From the American Heart Association

and the diverse perspectives of the experts on the writing group. The 10-member writing group for this statement is diverse in its demographic composition, disciplinary perspectives, and context expertise. It consists of 4 women, includes 2 underrepresented minorities, and comprises clinicians (internal medicine, cardiovascular physicians, and nurses) and clinician scientists engaged in health services research, epidemiology, health education, and behavioral health interventions. The committee is further (...) enhanced by individuals with expertise in social determinants of health (including health literacy) and cardiovascular health disparities affecting racial/ethnic minorities and rural populations and the development and evaluation of community-based interventions and strategies to promote health. Health Literacy: Definitions and Dimensions Measuring Literacy in the United States In 1992, the US Department of Education initiated the first population-based, in-person assessment of adult literacy

Full Text available with Trip Pro

2018 American Heart Association

208. Testosterone Therapy in Men with Hypogonadism

instances, educating patients that obesity or opioids may be contributing to hypogonadism could motivate them to lose weight or discontinue narcotic pain medications. Diagnosis of men with suspected hypogonadism 1.1 We recommend diagnosing hypogonadism in men with symptoms and signs of testosterone deficiency and unequivocally and consistently low serum total testosterone and/or free testosterone concentrations (when indicated). (1∣⊕⊕⊕O) Technical remark Testosterone concentrations exhibit significant

Full Text available with Trip Pro

2018 The Endocrine Society

209. AACE/ACE Comprehensive Type 2 Diabetes Management Algorithm

sequestrant; BCR-QR = bromocriptine quick release; BMI = body mass index; BP = blood pressure; CCB = calcium channel blocker; CHD = coronary heart disease; CKD = chronic kidney disease; CVD = cardio- vascular disease; DASH = Dietary Approaches to Stop Hypertension; DPP4 = dipeptidyl peptidase 4; eGFR = estimated glomerular filtration rate; ER = extended release; FDA = Food and Drug Administration; GLP1 = glucagon-like peptide 1; HDL-C = high-density lipoprotein cholesterol; IMPROVE-IT = Improved Reduction (...) and education. All patients should strive to attain and main- tain an optimal weight through a primarily plant-based meal plan high in polyunsaturated and monounsaturated fatty acids, with limited intake of saturated fatty acids and avoidance of trans fats. Patients with overweight (body mass index [BMI] 25-29.9 kg/m 2 ) or obesity (BMI =30 kg/ m 2 , see Obesity section) should also restrict their caloric intake with the goal of reducing body weight by at least 5 to 10%. As shown in the Look AHEAD (Action

2018 American Association of Clinical Endocrinologists

211. Induced Pluripotent Stem Cells for Cardiovascular Disease Modeling and Precision Medicine: A Scientific Statement From the American Heart Association

BMPR2 mutations. These findings suggest that iPSC-endothelial cells can model not only familial pulmonary arterial hypertension caused by BMPR2 mutations but also the effects of genetic modifiers of BMPR2 mutations resulting in an absence of disease. Metabolic Risk Factors for Ischemic Heart Disease Blood concentrations of lipids, namely, low-density lipoprotein cholesterol (LDL-C) and high-density lipoprotein cholesterol, are well-established risk factors for ischemic heart disease. A number (...) impaired LDL particle uptake, whereas the familial hypobetalipoproteinemia iPSC-hepatocytes displayed increased LDL particle uptake. Tangier disease, also known as hypoalphalipoproteinemia, is marked by abnormally low blood levels of high-density lipoprotein cholesterol caused by recessive mutations in ABCA1 (ATP-binding cassette subfamily A member 1). ABCA1 is the molecule that effluxes cholesterol from cells such as macrophages onto high-density lipoprotein particles and thus is a key mediator

Full Text available with Trip Pro

2018 American Heart Association

212. Sirens to Scrubs: Acute Coronary Syndromes Part Three – Diagnosis and ED Management

on Perioperative Cardiovascular Evaluation and Management of Patients Undergoing Noncardiac Surgery. Circulation . 2016;134(10):e123-55. [ ] 9. Ostadal P. Statins as first-line therapy for acute coronary syndrome? Exp Clin Cardiol . 2012;17(4):227-236. [ ] (Visited 606 times, 1 visits today) Paula Sneath Paula is a PGY1 in Emergency Medicine at McMaster University and an Advanced Care Paramedic in Ontario. She has a strong interest in improving access to education and resources for paramedics in Canada (...) ) – by blocking the HMG CoA reductase enzyme, statins decrease cholesterol formation in the liver. In addition, statins have been shown to moderate inflammation, oxidative stress, thrombus formation, and endothelial dysfunction. 9 These are also for life unless adverse effects develop (most commonly, muscle pain). Angiotensin-converting enzyme (ACE) inhibitors or angiotensin receptor blockers (ARBs) – lower blood pressure and also interfere with the remodeling process described above. Also for life unless

2018 CandiEM

213. Dietary Diversity: Implications for Obesity Prevention in Adult Populations: A Science Advisory From the American Heart Association

on Epidemiology and Prevention; Council on Functional Genomics and Translational Biology; and Council on Hypertension August 2016 September 11, 2018 Vol 138, Issue 11 Article Information Metrics Download : 6,700 © 2018 American Heart Association, Inc. PubMed Originally published August 9, 2018 Keywords Subjects Title Title Title Title Circulation AHA Journals Journal Information Subjects Features Resources & Education For Authors & Reviewers National Center 7373 Greenville Ave. Dallas, TX 75231 Customer (...) higher points for adequate daily intake of grains, vegetables, fruit, milk, meat, total fat, saturated fat, cholesterol, and sodium and for greater variety of food items, assessed with simple food count. Higher food-based diet quality scores, such as the HEI, Alternative HEI, and Dietary Approaches to Stop Hypertension, have consistently been associated with lower disease risk. Few previous studies have modified dietary diversity measures to reflect diet quality in addition to, or rather than

Full Text available with Trip Pro

2018 American Heart Association

214. Elagolix for Treating Endometriosis

that provide long-term relief with few side effects is thought to reflect insufficient knowledge of the underlying cause(s) of endometriosis. • Though medical therapies focus on suppressing the production of ovarian hormones, even complete suppression does not eliminate symptoms and cause bothersome side effects. • Risks of long-term use of therapies like GnRH agonists and antagonists include osteoporosis and adverse effects on cholesterol levels. • Moreover, medical therapies have not been shown (...) ? ? Consumption Future consumption unrelated to health ? ? Social services Cost of social services as part of intervention ? ? Legal/Criminal Justice Number of crimes related to intervention ? ? Cost of crimes related to intervention ? ? Education Impact of intervention on educational achievement of population ? ? Housing Cost of home improvements, remediation ? ? Environment Production of toxic waste pollution by intervention ? ? Other Other impacts (if relevant) ? ? Model Parameters Health Care Utilization

2018 California Technology Assessment Forum

216. Sodium and Potassium Intake: Effects on Chronic Disease Outcomes and Risks

medical reference and in conjunction with all other pertinent information, i.e., in the context of available resources and circumstances presented by individual patients. This report is made available to the public under the terms of a licensing agreement between the author and the Agency for Healthcare Research and Quality. This report may be used and reprinted without permission except those copyrighted materials that are clearly noted in the report. Further reproduction of those copyrighted (...) may increase is called the Tolerable Upper Intake Level (UL). The DRIs are for dietary intakes only (i.e., foods and dietary supplements) and are intended to cover the needs of almost all healthy persons. These values serve multiple purposes, including guidance for (a) health professionals for use in dietary counseling and for developing educational materials for consumers and patients, (b) scientists in designing and interpreting research, (c) ES-2 users of national nutrition monitoring, and (d

2018 Effective Health Care Program (AHRQ)

218. What is the evidence on the policy specifications, development processes and effectiveness of existing front-of-pack food labelling policies in the WHO European Region?

credible; • develop the scope of FOPL policies based on stakeholder engagement and formative research to ensure that the right policy is chosen for the population; • explore ways to overcome issues with uptake of the FOPL system in the marketplace, including through mandatory implementation; • support implementation through the development of guidance documents for industry to facilitate label adoption and public education initiatives to stimulate consumer demand for the label and improve awareness (...) of energy, saturated and trans-unsaturated (trans) fatty acids, sodium and free sugars and low intakes of fruits, vegetables and polyunsaturated fatty acids. Such dietary practices contribute to metabolic risk factors, including high blood pressure, high body mass index (commonly referred to as overweight and obesity), high fasting plasma glucose and high total cholesterol, which, in turn, increase risk for diet-related NCDs, including type 2 diabetes mellitus, cardiovascular diseases and some types

2018 WHO Health Evidence Network

219. Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency

) to improve the positive predictive value of congenital adrenal hyperplasia screening. (1|⊕⊕○○) Technical remark: Laboratories utilizing liquid chromatography–tandem mass spectrometry should participate in an appropriate quality assurance program. Additionally, clinicians should realize that immunoassays lead to more false-positive results. Thus, if laboratory resources do not include liquid chromatography–tandem mass spectrometry, a cosyntropin stimulation test should be performed to confirm diagnosis (...) educating patients and their guardians and close contacts on adrenal crisis prevention and increasing the dose of glucocorticoid (but not mineralocorticoid) during intercurrent illness. (1|⊕⊕⊕○) 4.11 We recommend equipping every patient with congenital adrenal hyperplasia with a glucocorticoid injection kit for emergency use and providing education on parenteral self-administration (young adult and older) or lay administration (parent or guardian) of emergency glucocorticoids. (1|⊕⊕⊕○) Monitoring

Full Text available with Trip Pro

2018 The Endocrine Society

220. Weight Loss to Prevent Obesity-Related Morbidity and Mortality in Adults: Behavioral Interventions

for cardiovascular disease prevention in adults with and without common risk factors , ( ). The USPSTF recommends that clinicians screen for obesity in children 6 years or older and offer or refer them to a comprehensive, intensive behavioral intervention (B recommendation). Useful Resources The Community Preventive Services Task Force recommends multicomponent interventions that use technology-supported coaching or counseling to help adults lose weight and maintain weight loss. Other Considerations Research (...) Angeles); Maureen G. Phipps, MD, MPH (Brown University, Providence, Rhode Island); Michael Silverstein, MD, MPH (Boston University, Boston, Massachusetts); Melissa A. Simon, MD, MPH (Northwestern University, Evanston, Illinois); Chien-Wen Tseng, MD, MPH, MSEE (University of Hawaii, Honolulu, and Pacific Health Research and Education Institute, Honolulu, Hawaii); John B. Wong, MD (Tufts University, Medford, Massachusetts). Copyright and Source Information Conflict of Interest Disclosures: All authors

2018 U.S. Preventive Services Task Force

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>